Form 4: Beneficient Officer Maria S. Rutledge Reports Stock Purchase
SEC Form 4
Maria S. Rutledge, Chief Technology Officer of Beneficient, reports purchasing 900 shares of Class A Common Stock at $1.11 per share.
Summary
- On September 20, 2024, Maria S. Rutledge, Chief Technology Officer of Beneficient, purchased 900 shares of Class A Common Stock at a price of $1.11 per share.
- Following this transaction, Rutledge directly owns 2,540 shares of Class A Common Stock.
- This includes shares issuable upon the settlement of restricted stock units (RSUs) and restricted equity units (REUs) granted under Beneficient's equity incentive plans.
- The reported share amounts have been retroactively adjusted to reflect a 1-for-80 reverse stock split that occurred on April 18, 2024.
Sentiment
Score: 5
Explanation: The sentiment is neutral. It's a routine disclosure of a stock purchase by an officer. While insider purchases can be seen as positive, the small size of the transaction doesn't strongly indicate bullishness.
Industry Context
Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company insiders. This filing indicates a purchase by a key officer, which could be interpreted as a positive signal, but the purchase is relatively small.
Comparison to Industry Standards
- Comparing this transaction to similar Form 4 filings of other small-cap companies, the purchase of 900 shares is a relatively small transaction.
- For example, executives at comparable firms like MicroVision or FuelCell Energy often trade larger volumes of shares, reflecting potentially different levels of confidence or compensation structures.
- The significance of this transaction should be considered in the context of Beneficient's overall financial health and recent performance, as well as the individual officer's compensation package.
Stakeholder Impact
- The purchase could have a slightly positive impact on shareholder sentiment, as it signals confidence from a company officer.
- However, the small size of the transaction limits the potential impact.
Key Dates
| Date | Description |
|---|---|
| January 1, 2020 | Date of grant of 875 restricted equity units (REUs) pursuant to The Beneficient Company Group, L.P. 2018 Equity Incentive Plan |
| April 1, 2022 | Date of grant of 81 REUs pursuant to the 2018 Equity Incentive Plan |
| July 15, 2023 | Date of grant of 482 restricted stock units (RSUs) granted pursuant to Beneficient 2023 Equity Incentive Plan |
| July 15, 2023 | Date of grant of 386 RSUs granted pursuant to 2023 Equity Incentive Plan |
| April 18, 2024 | Beneficient's reverse stock split of its outstanding shares of Class A common stock and Class B common stock on a 1-for-80 basis |
| September 20, 2024 | Date of transaction: Maria S. Rutledge purchased 900 shares of Class A Common Stock |
| September 27, 2024 | Date of Form 4 filing |
Keywords
Beneficient, Maria S. Rutledge, Class A Common Stock, Form 4, Officer, Stock Purchase, Equity Incentive Plan, RSU, REU, Reverse Stock Split
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.